{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:24:17Z","timestamp":1791894257186,"version":"4.3.4"},"reference-count":109,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ajog.2008.09.010","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T05:07:36Z","timestamp":1228972056000},"page":"596-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Use of metformin in polycystic ovary syndrome"],"prefix":"10.1016","volume":"199","author":[{"given":"Ruchi","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Trivax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2008.09.010_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib4","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/GRF.0b013e31803057ed","article-title":"Pregnancy considerations in women with polycystic ovary syndrome","volume":"50","author":"Legro","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2008.09.010_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ajog.2008.09.010_bib10","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib12","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib13","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib14","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1210\/jc.2003-030044","article-title":"Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone","volume":"88","author":"Legro","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/GRF.0b013e31802f3547","article-title":"The metabolic syndrome in polycystic ovary syndrome","volume":"50","author":"Essah","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib18","series-title":"PCOS, obesity, and reproductive function: RCOG special study group on obesity","author":"Balen","year":"2007"},{"key":"10.1016\/j.ajog.2008.09.010_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2007-992929","article-title":"Exercise therapy in polycystic ovary syndrome","volume":"26","author":"Hoeger","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib20","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib21","first-page":"3299","article-title":"The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib22","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0015-0282(98)00011-9","article-title":"Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome","volume":"69","author":"Morin-Papunen","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ajog.2008.09.010_bib29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajog.2008.09.010_bib30","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP activated protein kinase by the anti-diabetic drug metformin in vivo","volume":"279","author":"Zou","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajog.2008.09.010_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/molehr\/gal057","article-title":"The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice","volume":"12","author":"Elia","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib33","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 beta- hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajog.2008.09.010_bib34","first-page":"785","article-title":"Metformin for treatment of the polycystic ovary syndrome","volume":"101","author":"Barbieri","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib35","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib36","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib37","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2007-1393","article-title":"Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is\u2026","volume":"92","author":"Barbieri","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib38","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2008.09.010_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P-450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2008.09.010_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Uses of metformin in polycystic ovary syndrome: a meta analysis","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib43","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1136\/bmj.38867.631551.55","article-title":"Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomized double blind clinical trial","volume":"332","author":"Moll","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2008.09.010_bib44","article-title":"Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial","author":"Zain","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2005.04.043","article-title":"Metformin alters insulin signaling and viability of human granulosa cells","volume":"84","author":"Sonntag","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejogrb.2007.02.001","article-title":"Effect of metformin on IGF-1 and IGFBP-1 levels in obese patients with polycystic ovary syndrome","volume":"138","author":"Seibel","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2008.09.010_bib48","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1095\/biolreprod.106.055749","article-title":"Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5' monophosphate-activated protein kinase (AMPK)","volume":"76","author":"Tosca","year":"2007","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0015-0282(01)02941-7","article-title":"Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate resistant women with polycystic ovary syndrome","volume":"77","author":"Kocak","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib50","first-page":"663","article-title":"The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome","volume":"23","author":"Malkawi","year":"2002","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ajog.2008.09.010_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2005.04.004","article-title":"Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome","volume":"90","author":"Hwu","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2008.09.010_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.fertnstert.2005.07.1312","article-title":"A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome","volume":"85","author":"Rouzi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/eje.1.01866","article-title":"Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation?","volume":"152","author":"Van Santbrink","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/humrep\/17.2.289","article-title":"Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial","volume":"17","author":"Yarali","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib56","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/humrep\/dei130","article-title":"A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination","volume":"20","author":"Palomba","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib57","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib58","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotropin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib59","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09513590701214398","article-title":"Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia","volume":"23","author":"Genazzani","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib61","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib62","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmm026","article-title":"The role of metformin in polycystic ovary syndrome: a systematic review","volume":"13","author":"Moll","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2008.09.010_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib65","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/humrep\/dei351","article-title":"Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib68","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib69","article-title":"Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2008.09.010_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib71","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Combination estrogen-progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.fertnstert.2006.02.098","article-title":"Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis","volume":"86","author":"Gilbert","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humrep\/deh109","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14767050600682370","article-title":"Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy","volume":"19","author":"Kovo","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1464-5491.2000.00314.x","article-title":"Oral hypoglycemic agents in 118 diabetic pregnancies","volume":"17","author":"Hellmuth","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib76","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ajog.2008.09.010_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/09513590701260193","article-title":"Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance","volume":"23","author":"Nawrocka","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09513590701192529","article-title":"Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity","volume":"23","author":"Marcondes","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09513590400004736","article-title":"Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study","volume":"19","author":"Sahin","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib80","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ajog.2008.09.010_bib81","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajog.2008.09.010_bib83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","article-title":"Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome","volume":"73","author":"Kolodziejczyk","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.09.010_bib84","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.0.1470217","article-title":"The effect of metformin on hirsutism in polycystic ovary syndrome","volume":"147","author":"Kelly","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib85","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl-estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib86","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib87","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib88","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2008.09.010_bib90","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib91","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib92","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib93","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus","volume":"121","author":"Salpeter","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib95","first-page":"3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl-estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized trial","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib97","article-title":"Insulin-sensitizing drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"1","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2008.09.010_bib98","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl-estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.09.010_bib100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4158\/EP.13.4.373","article-title":"Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis","volume":"13","author":"Sharma","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2008.09.010_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome: a randomized, placebo-controlled, double-blind multicenter study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib102","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajog.2008.09.010_bib103","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/01443610400007810","article-title":"Polycystic ovary syndrome, diabetes and cardiovascular disease: risk and risk factors","volume":"24","author":"Lakhani","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2008.09.010_bib104","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome","volume":"152","author":"Rautio","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/eje.1.01948","article-title":"Effects of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome","volume":"153","author":"Tarkun","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2008.09.010_bib106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.2006.02551.x","article-title":"Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance","volume":"65","author":"Topcu","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2008.09.010_bib107","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/humrep\/del003","article-title":"Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin","volume":"21","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2008.09.010_bib108","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2008.09.010_bib109","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2013a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808010478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808010478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:28:38Z","timestamp":1757586518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937808010478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":109,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0002937808010478"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2008.09.010","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of metformin in polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2008.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}